Il campionamento bioptico prostatico transrettale ecoguidato iterativo in pazienti con esame istologico negativo.

Translated title of the contribution: Repeated ultrasound-guided transrectal prostate biopsy in patients with negative histologic test

M. Raber, V. Scattoni, A. Salonia, P. Consonni, P. Rigatti

Research output: Contribution to journalArticle

Abstract

The screening programs for prostate cancer will affect a number increasing of patients over 50 years with consequence rising the bioptic demand. Nevertheless the istopathologic results are negatives for carcinoma in the most part of patients. It's evident that a part of carcinomas are lost at biopsy. Two hundred four patients where submitted at second bioptic session after a maximum of 12 months. Our results show a percent probability of positive findings in 12%. In 75% cancer diagnosed in that second session had clinically significance. Prostate specific antigen (PSA) value, in our study, is the most positive predictive parameter for prostate cancer at second biopsy. Patients with PSA > 10 ng/ml have a risk 7 times greater of having a prostatic cancer respect to patients with PSA <10 ng/ml. PSA density, PSA velocity and the presence of ipoecoic areas previously biopsied, aren't risk factors for detection of prostate cancer at second bioptic session.

Original languageItalian
Pages (from-to)197-199
Number of pages3
JournalArchivio Italiano di Urologia e Andrologia
Volume72
Issue number4
Publication statusPublished - Dec 2000

Fingerprint

Prostate-Specific Antigen
Prostate
Prostatic Neoplasms
Biopsy
Carcinoma
Neoplasms

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Il campionamento bioptico prostatico transrettale ecoguidato iterativo in pazienti con esame istologico negativo. / Raber, M.; Scattoni, V.; Salonia, A.; Consonni, P.; Rigatti, P.

In: Archivio Italiano di Urologia e Andrologia, Vol. 72, No. 4, 12.2000, p. 197-199.

Research output: Contribution to journalArticle

@article{3001fd45b8bc46888621181838089caf,
title = "Il campionamento bioptico prostatico transrettale ecoguidato iterativo in pazienti con esame istologico negativo.",
abstract = "The screening programs for prostate cancer will affect a number increasing of patients over 50 years with consequence rising the bioptic demand. Nevertheless the istopathologic results are negatives for carcinoma in the most part of patients. It's evident that a part of carcinomas are lost at biopsy. Two hundred four patients where submitted at second bioptic session after a maximum of 12 months. Our results show a percent probability of positive findings in 12{\%}. In 75{\%} cancer diagnosed in that second session had clinically significance. Prostate specific antigen (PSA) value, in our study, is the most positive predictive parameter for prostate cancer at second biopsy. Patients with PSA > 10 ng/ml have a risk 7 times greater of having a prostatic cancer respect to patients with PSA <10 ng/ml. PSA density, PSA velocity and the presence of ipoecoic areas previously biopsied, aren't risk factors for detection of prostate cancer at second bioptic session.",
author = "M. Raber and V. Scattoni and A. Salonia and P. Consonni and P. Rigatti",
year = "2000",
month = "12",
language = "Italian",
volume = "72",
pages = "197--199",
journal = "Archivio Italiano di Urologia Nefrologia Andrologia",
issn = "1120-8538",
publisher = "Edizioni Scripta Manent s.n.c.",
number = "4",

}

TY - JOUR

T1 - Il campionamento bioptico prostatico transrettale ecoguidato iterativo in pazienti con esame istologico negativo.

AU - Raber, M.

AU - Scattoni, V.

AU - Salonia, A.

AU - Consonni, P.

AU - Rigatti, P.

PY - 2000/12

Y1 - 2000/12

N2 - The screening programs for prostate cancer will affect a number increasing of patients over 50 years with consequence rising the bioptic demand. Nevertheless the istopathologic results are negatives for carcinoma in the most part of patients. It's evident that a part of carcinomas are lost at biopsy. Two hundred four patients where submitted at second bioptic session after a maximum of 12 months. Our results show a percent probability of positive findings in 12%. In 75% cancer diagnosed in that second session had clinically significance. Prostate specific antigen (PSA) value, in our study, is the most positive predictive parameter for prostate cancer at second biopsy. Patients with PSA > 10 ng/ml have a risk 7 times greater of having a prostatic cancer respect to patients with PSA <10 ng/ml. PSA density, PSA velocity and the presence of ipoecoic areas previously biopsied, aren't risk factors for detection of prostate cancer at second bioptic session.

AB - The screening programs for prostate cancer will affect a number increasing of patients over 50 years with consequence rising the bioptic demand. Nevertheless the istopathologic results are negatives for carcinoma in the most part of patients. It's evident that a part of carcinomas are lost at biopsy. Two hundred four patients where submitted at second bioptic session after a maximum of 12 months. Our results show a percent probability of positive findings in 12%. In 75% cancer diagnosed in that second session had clinically significance. Prostate specific antigen (PSA) value, in our study, is the most positive predictive parameter for prostate cancer at second biopsy. Patients with PSA > 10 ng/ml have a risk 7 times greater of having a prostatic cancer respect to patients with PSA <10 ng/ml. PSA density, PSA velocity and the presence of ipoecoic areas previously biopsied, aren't risk factors for detection of prostate cancer at second bioptic session.

UR - http://www.scopus.com/inward/record.url?scp=0034569047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034569047&partnerID=8YFLogxK

M3 - Articolo

C2 - 11221036

AN - SCOPUS:0034569047

VL - 72

SP - 197

EP - 199

JO - Archivio Italiano di Urologia Nefrologia Andrologia

JF - Archivio Italiano di Urologia Nefrologia Andrologia

SN - 1120-8538

IS - 4

ER -